How a Biogen drug set the stage for a new biotech targeting ALS

How a Biogen drug set the stage for a new biotech targeting ALS

Submitted by admin on November 17, 2024 - 9:27pm
Source: 
BioPharma Dive
News Tags: 
Biogen
Trace Neuroscience
Qalsody
ALS
Headline: 
How a Biogen drug set the stage for a new biotech targeting ALS
snippet: 

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke with BioPharma Dive about how the company came together.

Do Not Allow Advertisers to Use My Personal information